3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
4
Recurrence
3
Solid Tumor Malignancy
1
Sarcoma, Ewing
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdoid Tumor
1
Recurrent Squamous Cell Lung Carcinoma
1
Neurofibrosarcoma
1
Neoplasm, Residual
1
Lymphoma, Large B-Cell, Diffuse
1
Liposarcoma
1
Immunoglobulin Light-chain Amyloidosis
1
Central Nervous System Neoplasms
1
Amyloidosis
1
Alzheimer Disease
1
Interventions
Dexamethasone
2
venetoclax
1
selinexor
1
ethanolamine oleate
1
daratumumab
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Sulfamethoxazole
1
Sodium Chloride
1
Saline Solution, Hypertonic
1
Saline Solution
1
Psychiatric Rehabilitation
1
Pentetic Acid
1
In Situ Hybridization, Fluorescence
1
In Situ Hybridization
1
Ethanol
1
Edetic Acid
1
Drug Therapy
1
Calcium Dobesilate
1
Biological Assay
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Immunoglobulin Light-chain Amyloidosis
×
selinexor
×
Clear all
NCT04984330
2022-11-17
STARR
Weill Medical College of Cornell University
Phase EARLY_PHASE1
Withdrawn